Peter S. Chung

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference”.

Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference

Alzheimer s & Dementia(2025)10.1002/alz.70078

N/A

0.330DataRank · unranked

8 citations

James B. Rowe, Rufus Akinyemi, Jose F. Abisambra, Nicholas J. Ashton, Matthias Brendel +38 more

Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI)

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.09.002

N/A

0.208DataRank · unranked

3 citations

Eunjin Hong, Peter S. Chung, Adupa P. Rao, Whitaker Cohn, Paul M. Beringer +1 more

Predicting Maternal and Fetal Exposures of Elexacaftor–Tezacaftor–Ivacaftor during Pregnancy through Physiologically Based Pharmacokinetic Models

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3705

N/A

0DataRank · unranked

9 citations

Mary Hebert, Emily Fay, G. Turner, Patricia H. Eshaghian, Aaron Trimble +4 more